RG
PRAH

Redmile Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Redmile Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-265,736
Closed -$33.3M – 101
2020
Q4 		$33.3M Sell
265,736
-12,200
-4% -$1.36M 0.4% 54
2020
Q3 		$28.2M Sell
277,936
-1,400
-0.5% -$143K 0.52% 50
2020
Q2 		$27.2M Sell
279,336
-163,364
-37% -$15.2M 0.5% 51
2020
Q1 		$36.8M Sell
442,700
-7,100
-2% -$692K 1.03% 31
2019
Q4 		$50M Buy
449,800
+54,400
+14% +$5.6M 1.2% 26
2019
Q3 		$39.2M Buy
+395,400
New +$39.3M 1.31% 24
2019
Q2 		– Sell
-174,000
Closed -$19.2M – 97
2019
Q1 		$19.2M Sell
174,000
-20,800
-11% -$2.17M 0.56% 47
2018
Q4 		$17.9M Sell
194,800
-5,200
-3% -$526K 0.72% 43
2018
Q3 		$22M Buy
+200,000
New +$20.8M 0.68% 51
2018
Q2 		– Sell
-245,314
Closed -$20.4M – 89
2018
Q1 		$20.4M Sell
245,314
-5,300
-2% -$471K 0.79% 38
2017
Q4 		$22.8M Sell
250,614
-151,400
-38% -$12.6M 0.99% 37
2017
Q3 		$30.6M Buy
+402,014
New +$30.4M 1.51% 24

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Redmile Group's PRAH Position: Q1 2021 in Review

Redmile Group sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 265,736 shares — an estimated $33.3M sold.

Redmile Group first reported a position in PRAH in Q3 2017 and held it in 12 quarters. The position peaked at $50M in Q4 2019. 323 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Redmile Group reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Redmile Group sold 265,736 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $33.3M.
  • Redmile Group first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 12 quarters.
  • Redmile Group's PRA Health Sciences, Inc. position peaked at $50M in Q4 2019.
  • 323 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Redmile Group's 13F filing for Q1 2021, filed 17 May 2021.